What is the current Price Target for the Immunovant Inc stock?

The average Immunovant Inc target price is $48.36. This is 138.83% higher than the current stock price. The highest price target is 186.42%, the lowest is 87.65%. 11 Analysts have issued a price target Immunovant Inc 2026 .

How high will the Immunovant Inc stock rise?

No reliable answer can be given as to how high the Immunovant Inc stock will rise. The performance of stocks, including the Immunovant Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Immunovant Inc stock today?

The performance of Immunovant Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Immunovant Inc stock fall?

The decline in Immunovant Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Immunovant Inc Forecast, price target & analysts

$20.41

0.79% today

Nasdaq, Feb 28, 08:19 pm CET

ISIN

US45258J1025

Symbol

IMVT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Finances

Industry

Financial service provider

Overview Dividends Analysts Charts News Strategies

Immunovant Inc Target price 2025 - Analyst rating & recommendation

Immunovant Inc Classifications & Recommendation:

Buy

92%

Hold

Immunovant Inc Price Target

Target Price	$48.36
Price	$20.25
Potential	138.83% register free of charge
Number of Estimates	11

	11 Analysts have issued a price target Immunovant Inc 2026 . The average Immunovant Inc target price is $48.36. This is 138.83% register free of charge higher than the current stock price. The highest price target is $58.00 186.42% register free of charge , the lowest is $38.00 87.65% register free of charge .
	A rating was issued by 13 analysts: 12 Analysts recommend Immunovant Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Immunovant Inc stock has an average upside potential 2026 of 138.83% register free of charge . Most analysts recommend the Immunovant Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Mar '24	2025 Estimates
Earnings Per Share $	-1.88	-2.75
	9.94%	46.28%
P/E		negative

5 Analysts have issued a Immunovant Inc forecast for earnings per share. The average Immunovant Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.88	9.94%
2025	$-2.75 46.28% Unlock
2026	$-3.09 12.36% Unlock
2027	$-3.28 6.15% Unlock
2028	$-2.59 21.04% Unlock
2029	$0.83 132.05% Unlock

Current	-7.74	61.76%
2025	-7.36 4.91% Unlock
2026	-6.55 11.01% Unlock
2027	-6.17 5.80% Unlock
2028	-7.82 26.74% Unlock
2029	24.55 413.94% Unlock

Immunovant Inc...

Current Immunovant Inc Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Feb 10 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 10 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 07 2025
B of A Securities	Locked ➜ Locked	Locked	Jan 15 2025
Wolfe Research	Locked ➜ Locked	Locked	Jan 03 2025
Wells Fargo	Locked ➜ Locked	Locked	Dec 19 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 08 2024

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Feb 10 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 10 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 07 2025
Locked B of A Securities: Locked ➜ Locked	Jan 15 2025
Locked Wolfe Research: Locked ➜ Locked	Jan 03 2025
Locked Wells Fargo: Locked ➜ Locked	Dec 19 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 08 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now